Tìm theo
E2012
Thuốc Gốc
Small Molecule
CTHH: C21H32O2
PTK: 316.4776
E2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease.
Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
C21H32O2
Phân tử khối
316.4776
Monoisotopic mass
316.240230268
InChI
InChI=1S/C21H32O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23-2/h4-5,7-8,10-11,13-14,16-17H,3,6,9,12,15,18-20H2,1-2H3/b5-4-,8-7-,11-10-,14-13-,17-16-
InChI Key
InChIKey=QWDCYFDDFPWISL-JEBPEJKESA-N
IUPAC Name
methyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Traditional IUPAC Name
methyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
SMILES
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC
Độ hòa tan
1.16e-04 g/l
logP
6.37
logS
-6.4
pKa (Strongest Basic)
-7
PSA
26.3 Å2
Refractivity
105.84 m3·mol-1
Polarizability
38.38 Å3
Rotatable Bond Count
14
H Bond Acceptor Count
1
H Bond Donor Count
0
Physiological Charge
0
Number of Rings
0
Bioavailability
0
Cơ Chế Tác Dụng : E2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease. Gamma secretase plays a role in the production of beta-amyloid, a major component of plaque in the brain, which is thought to be a cause of Alzheimer's disease. E2012 is a new chemical entity discovered by Eisai and, in preclinical (laboratory) research, has shown some potential to reduce the production of beta-amyloid by modulating the function of gamma secretase.
Chỉ Định : Investigated for use/treatment in alzheimer's disease.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05171
PubChem Compound
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=6421261
PubChem Substance
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=10361696
ChemSpider
http://www.chemspider.com/Chemical-Structure.4926802.html
... loading
... loading